Werewolf Therapeutics, Inc.
HOWL
$0.39
$0.001.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.61M | -56.27M | -60.82M | -72.84M | -73.14M |
| Total Depreciation and Amortization | 3.65M | 1.61M | 1.63M | 1.68M | 1.73M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.19M | 5.66M | 7.10M | 9.61M | 10.19M |
| Change in Net Operating Assets | -5.38M | -2.94M | -8.21M | -1.97M | 405.00K |
| Cash from Operations | -30.15M | -51.94M | -60.29M | -63.52M | -60.83M |
| Capital Expenditure | -- | -- | -- | -123.00K | -126.00K |
| Sale of Property, Plant, and Equipment | 416.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 416.00K | -- | -- | -123.00K | -126.00K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -32.41M | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 5.64M | 6.03M | 6.03M | 6.21M | 2.94M |
| Repurchase of Common Stock | -- | -- | -- | -- | -6.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | -26.77M | 6.03M | 6.03M | 6.21M | 2.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -56.50M | -45.91M | -54.26M | -57.43M | -58.02M |